February 23, 2015

Empagliflozin, an SGLT2 Inhibitor for the Treatment of Type 2 Diabetes Mellitus

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

The oral antidiabetes agent, empagliflozin, can be used as monotherapy or alongside other glucose-lowering treatments, including insulin, to treat T2DM.

Me gusta

Guardar

Cite This Study

John R. White (Mon,) studied this question.

synapsesocial.com/papers/69d570d875589c71d767df6c https://doi.org/https://doi.org/10.1177/1060028015573564

Me gusta

Guardar